Health Products Act (Cap. 122D)
Overview
The Health Products Act (Cap. 122D) (HPA) is the primary legislation governing the regulation of health products in Singapore, including medical devices. It was first enacted in 2007 (as the Health Products Act 2007) and has been amended several times since.
The HPA establishes:
- HSA's powers to regulate health products;
- The scope of regulated products (medical devices, therapeutic products, health supplements, etc.);
- The licensing and registration frameworks;
- Offences and penalties for non-compliance;
- HSA's enforcement powers (inspections, seizure, recall directions).
The full text is available at: sso.agc.gov.sg/Act/HPA2007
Key provisions for medical devices
| Section | Content |
|---|---|
| Section 2 | Definitions — including "medical device," "dealer," "registrant," "manufacturer," "importer," "wholesaler" |
| Section 14 | Prohibition on supplying unregistered health products (including medical devices) |
| Section 17 | Registration of health products — the basis for HSA's product registration powers |
| Part 3 | Licensing of dealers |
| Section 40 | Adverse event reporting obligations |
| Part 6 | HSA's enforcement powers — inspections, seizure, recall directions |
| Part 7 | Offences and penalties |
Always refer to the current consolidated version on Singapore Statutes Online, as section numbers and content may change with amendments.
Penalties
Non-compliance with the HPA carries significant penalties. Supplying an unregistered medical device or dealing without a licence are criminal offences under the Act, with penalties including fines and imprisonment. See the current Act text for the applicable penalty provisions.